Genetics team recruits first patient to new trial
Monday 31st July 2017
We are proud to say our genetics team has just recruited its first patient to a trial which could bring new hope to patients with the terminal condition Huntington’s disease.
Huntington’s disease is caused by a faulty gene in one of the body’s chromosomes causing harm in the brain, causing problems with control of movement, behaviour and thinking.
Symptoms include mood problems, involuntary bodily movements and behavourial changes, such as unpredictable emotions and difficulty with memory and thinking.
Researchers at Chapel Allerton Hospital and Leeds General Infirmary will be taking samples of cerebrospinal fluid to help get a better understanding of the disease.
Leeds Teaching Hospitals NHS Trust is one of six sites worldwide, and expects to collect samples from around 30 patients over the next two years.
Callum Schofield, genetics research practitioner and study coordinator, said: “We we will be collecting patients’ cerebrospinal fluid via lumber puncture, which is a procedure which our clinicians have done thousands of times and it really is the only way to collect samples.”
Our picture shows (left to right) Dr. Jeremy Cosgrove - Consultant Neurologist, Callum Schofield - Genetics Research Practitioner, Alan Liu - Genetics Research Nurse, Dr. Emma Hobson - Consultant Clinical Geneticist and Helena Baker - Biomedical Scientist.